Apolipoprotein C-III is a major protein constituent of triglyceride rich lipoproteins and HDL. It occurs in plasma in three isoforms differing by their sialic acid content. Apo C-III putatively inhibits lipolysis and the apo E mediated hepatic uptake of remnants from triglyceride rich particles. We identified a heterozygous carrier of an apolipoprotein C-III variant by the presence of additional bands after isoelectric focusing (IEF) of VLDL. Structural analysis of the variant protein by HPLC, time-of-flight secondary ion mass spectrometry, and automated gas phase sequencing revealed a lysine to glutamic acid replacement in position 58. The underlying A to G exchange was verified by direct sequencing subsequent to amplification by polymerase chain reaction of exon 4 of the apo C-III gene. Family studies revealed vertical transmission of this defect. The two variant carriers exhibited plasma concentrations of HDL cholesterol and apo A-I above the 95th percentiles of sex matched controls whereas the unaffected father and sister showed normal values. The plasma concentrations of apo C-III in the two variant carriers were decreased by 30-40% compared with those of the two unaffected family members and to random controls. Using two-dimensional immunoelectrophoresis as well as IEF and subsequent scanning densitometry, we found that the low serum concentration of apo C-III was a consequence of diminished concentrations of the variant apo C-III isoproteins in both VLDL (15% of normal) and HDL (25% of normal). Apo C-III(Lys58----Glu) heterozygotes possessed unusual HDL as demonstrated by nondenaturing gradient gel electrophoresis. They consisted mainly of HDL2b and contained a proportion of atypically large particles, enriched in apo E, with a Stokes diameter of 13-18 nm and resembling HDLc. In conclusion, heterozygosity for a structural apo C-III variant--apo C-III(Lys58----Glu)--was identified in two hyperalphalipoproteinemic subjects characterized by the presence of low plasma apo C-III concentrations and atypically large HDL.
A von Eckardstein, H Holz, M Sandkamp, W Weng, H Funke, G Assmann
Title and authors | Publication | Year |
---|---|---|
Exploring apolipoprotein C-III: pathophysiological and pharmacological relevance.
Packard CJ, Pirillo A, Tsimikas S, Ference BA, Catapano AL |
Cardiovascular research | 2024 |
Genetics and regulation of HDL metabolism
D Kardassis, E Thymiakou, A Chroni |
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 2022 |
Hyperalphalipoproteinemia and Beyond: The Role of HDL in Cardiovascular Diseases
A Giammanco, D Noto, CM Barbagallo, E Nardi, R Caldarella, M Ciaccio, MR Averna, AB Cefalù |
Life Sciences | 2021 |
Lipid Transfer in Lipoprotein Metabolism and Cardiovascular Disease
XC Jiang |
2020 | |
Lipid Transfer in Lipoprotein Metabolism and Cardiovascular Disease
XC Jiang |
2020 | |
Lipid Transfer in Lipoprotein Metabolism and Cardiovascular Disease
XC Jiang |
2020 | |
Lipid Transfer in Lipoprotein Metabolism and Cardiovascular Disease
XC Jiang |
2020 | |
Lipid Transfer in Lipoprotein Metabolism and Cardiovascular Disease
XC Jiang |
2020 | |
Lipid Transfer in Lipoprotein Metabolism and Cardiovascular Disease
XC Jiang |
2020 | |
Lipid Transfer in Lipoprotein Metabolism and Cardiovascular Disease
XC Jiang |
2020 | |
Metabolic characterisation of disturbances in the APOC3/triglyceride-rich lipoprotein pathway through sample-based recall by genotype
LJ Corbin, DA Hughes, AJ Chetwynd, AE Taylor, AD Southam, A Jankevics, RJ Weber, A Groom, WB Dunn, NJ Timpson |
Metabolomics | 2020 |
ApoCIII: A multifaceted protein in cardiometabolic disease
DE Laura, DC Alessia, A Gallo, E Bruckert, A Marcello |
Metabolism | 2020 |
HDL Dysfunction Caused by Mutations in apoA-I and Other Genes that are Critical for HDL Biogenesis and Remodeling
A Chroni, D Kardassis |
Current medicinal chemistry | 2019 |
Non-alcoholic fatty liver disease: a narrative review of genetics
Christopher J Danford, Ze-Min Yao, Z Gordon Jiang |
Journal of Biomedical Research | 2018 |
The apolipoprotein C-III (Gln38Lys) variant associated with human hypertriglyceridemia is a gain-of-function mutation
M Sundaram, KR Curtis, MA Alipour, ND LeBlond, KD Margison, RA Yaworski, RJ Parks, AD McIntyre, RA Hegele, MD Fullerton, Z Yao |
Journal of lipid research | 2017 |
Aromatic residues in the C terminus of apolipoprotein C-III mediate lipid binding and LPL inhibition
NL Meyers, M Larsson, E Vorrsjö, G Olivecrona, DM Small |
Journal of lipid research | 2017 |
Dysfunctional high-density lipoproteins in coronary heart disease: implications for diagnostics and therapy
W Annema, A Eckardstein |
Translational Research | 2016 |
D25V apolipoprotein C-III variant causes dominant hereditary systemic amyloidosis and confers cardiovascular protective lipoprotein profile
S Valleix, G Verona, N Jourde-Chiche, B Nédelec, PP Mangione, F Bridoux, A Mangé, A Dogan, JM Goujon, M Lhomme, C Dauteuille, M Chabert, R Porcari, CA Waudby, A Relini, PJ Talmud, O Kovrov, G Olivecrona, M Stoppini, J Christodoulou, PN Hawkins, G Grateau, M Delpech, A Kontush, JD Gillmore, AD Kalopissis, V Bellotti |
Nature Communications | 2016 |
Apolipoprotein CIII overexpression exacerbates diet-induced obesity due to adipose tissue higher exogenous lipid uptake and retention and lower lipolysis rates
HF Raposo, AA Paiva, LS Kato, HC de Oliveira |
Nutrition & Metabolism | 2015 |
Glycomic Analysis of High Density Lipoprotein Shows a Highly Sialylated Particle
J Huang, H Lee, AM Zivkovic, JT Smilowitz, N Rivera, JB German, CB Lebrilla |
Journal of Proteome Research | 2014 |
Monogenic causes of elevated HDL cholesterol and implications for development of new therapeutics
DB Larach, M Cuchel, DJ Rader |
Clinical Lipidology | 2013 |
Hepatic trans-Golgi action coordinated by the GTPase ARFRP1 is crucial for lipoprotein lipidation and assembly
D Hesse, K Radloff, A Jaschke, M Lagerpusch, B Chung, A Tailleux, B Staels, A Schurmann |
Journal of lipid research | 2013 |
Two novel mutations in apolipoprotein C3 underlie atheroprotective lipid profiles in families: Two novel mutations in apolipoprotein C3
AE Bochem, JC Capelleveen, GM Dallinga-Thie, AW Schimmel, MM Motazacker, I Tietjen, RR Singaraja, MR Hayden, JJ Kastelein, ES Stroes, GK Hovingh |
Clinical Genetics | 2013 |
Innovative technique for the direct determination of proteins in calcified aortic valves
L Coufalova, S Kuckova, M Velcovska, A Zeman, M Smid, M Havelcova, R Hynek |
Analytical and Bioanalytical Chemistry | 2013 |
A rare functional cardioprotective APOC3 variant has risen in frequency in distinct population isolates
I Tachmazidou, G Dedoussis, L Southam, AE Farmaki, GR Ritchie, DK Xifara, A Matchan, K Hatzikotoulas, NW Rayner, Y Chen, TI Pollin, JR O'Connell, LM Yerges-Armstrong, C Kiagiadaki, K Panoutsopoulou, J Schwartzentruber, L Moutsianas, , E Tsafantakis, C Tyler-Smith, G McVean, Y Xue, E Zeggini |
Nature Communications | 2013 |
Apolipoproteins C-I and C-III Inhibit Lipoprotein Lipase Activity by Displacement of the Enzyme from Lipid Droplets
M Larsson, E Vorrsjo, P Talmud, A Lookene, G Olivecrona |
The Journal of biological chemistry | 2013 |
Segregation of LIPG, CETP, and GALNT2 Mutations in Caucasian Families with Extremely High HDL Cholesterol
I Tietjen, GK Hovingh, RR Singaraja, C Radomski, A Barhdadi, J McEwen, E Chan, M Mattice, A Legendre, PL Franchini, MP Dubé, JJ Kastelein, MR Hayden |
PloS one | 2012 |
Metabolic, hormonal and stress-related molecular changes in <i>post-mortem</i> pituitary glands from schizophrenia subjects
D Krishnamurthy, LW Harris, Y Levin, TA Koutroukides, H Rahmoune, S Pietsch, N Vanattou-Saifoudine, FM Leweke, PC Guest, S Bahn |
World Journal of Biological Psychiatry | 2012 |
Apolipoprotein C-III and hepatic triglyceride-rich lipoprotein production :
Z Yao, Y Wang |
Current Opinion in Lipidology | 2012 |
Uremia Alters HDL Composition and Function
M Holzer, R Birner-Gruenberger, T Stojakovic, D El-Gamal, V Binder, C Wadsack, A Heinemann, G Marsche |
Journal of the American Society of Nephrology : JASN | 2011 |
Missense Mutation in APOC3 within the C-terminal Lipid Binding Domain of Human ApoC-III Results in Impaired Assembly and Secretion of Triacylglycerol-rich Very Low Density Lipoproteins
W Qin, M Sundaram, Y Wang, H Zhou, S Zhong, CC Chang, S Manhas, EF Yao, RJ Parks, PJ McFie, SJ Stone, ZG Jiang, C Wang, D Figeys, W Jia, Z Yao |
The Journal of biological chemistry | 2011 |
Visceral obesity modulates the impact of apolipoprotein C3 gene variants on liver fat content
A Peter, K Kantartzis, F Machicao, J Machann, S Wagner, S Templin, I Königsrainer, A Königsrainer, F Schick, A Fritsche, HU Häring, N Stefan |
International Journal of Obesity | 2011 |
Henry's Clinical Diagnosis and Management by Laboratory Methods
JL Miller, AK Rao |
Henry's Clinical Diagnosis and Management by Laboratory Methods | 2011 |
Missense Mutation in APOC3 within the C-terminal Lipid Binding Domain of Human ApoC-III Results in Impaired Assembly and Secretion of Triacylglycerol-rich Very Low Density Lipoproteins: EVIDENCE THAT ApoC-III PLAYS A MAJOR ROLE IN THE FORMATION OF LIPID PRECURSORS WITHIN THE MICROSOMAL LUMEN
W Qin, M Sundaram, Y Wang, H Zhou, S Zhong, CC Chang, S Manhas, EF Yao, RJ Parks, PJ McFie, SJ Stone, ZG Jiang, C Wang, D Figeys, W Jia, Z Yao |
The Journal of biological chemistry | 2011 |
Functional analysis of the missense APOC3 mutation Ala23Thr associated with human hypotriglyceridemia
M Sundaram, S Zhong, MB Khalil, H Zhou, ZG Jiang, Y Zhao, J Iqbal, MM Hussain, D Figeys, Y Wang, Z Yao |
Journal of lipid research | 2010 |
Functional analysis of the missense APOC3 mutation Ala23Thr associated with human hypotriglyceridemia
M Sundaram, S Zhong, MB Khalil, H Zhou, ZG Jiang, Y Zhao, J Iqbal, MM Hussain, D Figeys, Y Wang, Z Yao |
Journal of lipid research | 2010 |
Novel mutations of CETP gene in Italian subjects with hyeralphalipoproteinemia
AB Cefalù, D Noto, L Magnolo, E Pinotti, M Gomaraschi, S Martini, GB Vigna, L Calabresi, P Tarugi, MR Averna |
Atherosclerosis | 2009 |
Genomic susceptibility Loci for brain atrophy, ventricular volume, and leukoaraiosis in hypertensive sibships
ST Turner, M Fornage, CR Jack, TH Mosley, DS Knopman, SL Kardia, E Boerwinkle, M Andrade |
Archives of neurology | 2009 |
A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection
TI Pollin, CM Damcott, H Shen, SH Ott, J Shelton, RB Horenstein, W Post, JC McLenithan, LF Bielak, PA Peyser, BD Mitchell, M Miller, JR O'Connell, AR Shuldiner |
Science | 2008 |
Top-down proteomic analysis by MALDI-TOF profiling: Concentration-independent biomarkers
GL Nelsestuen, SB Harvey, Y Zhang, RS Kasthuri, AR Sinaiko, EW Ely, GR Bernard, M Homoncik, B Jilma |
PROTEOMICS – CLINICAL APPLICATIONS | 2008 |
An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?
DC Chan, MM Chen, EM Ooi, GF Watts |
International Journal of Clinical Practice | 2008 |
Structure and Dynamics of Human Apolipoprotein CIII
CS Gangabadage, J Zdunek, M Tessari, S Nilsson, G Olivecrona, SS Wijmenga |
The Journal of biological chemistry | 2008 |
Overexpression of apolipoprotein CIII increases and CETP reverses diet-induced obesity in transgenic mice
AG Salerno, TR Silva, ME Amaral, LC Alberici, ML Bonfleur, PR Patrício, EP Francesconi, DM Grassi-Kassisse, AE Vercesi, AC Boschero, HC Oliveira |
International Journal of Obesity | 2007 |
A functional polymorphism of apolipoprotein C1 detected by mass spectrometry
MS Wroblewski, JT Wilson-Grady, MB Martinez, RS Kasthuri, KR McMillan, C Flood-Urdangarin, GL Nelsestuen |
FEBS Journal | 2006 |
Plasma protein profiling: Unique and stable features of individuals
GL Nelsestuen, Y Zhang, MB Martinez, NS Key, B Jilma, M Verneris, A Sinaiko, RS Kasthuri |
PROTEOMICS | 2005 |
International Review of Neurobiology
ZT Bloomgarden |
International review of neurobiology | 2005 |
Increased apoC-III production is a characteristic feature of patients with hypertriglyceridemia
JS Cohn, M Tremblay, R Batal, H Jacques, C Rodriguez, G Steiner, O Mamer, J Davignon |
Atherosclerosis | 2004 |
The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism?
KW van Dijk, PC Rensen, PJ Voshol, LM Havekes |
Current Opinion in Lipidology | 2004 |
Apolipoprotein C-III Isofocusing in the Diagnosis of Genetic Defects in O-Glycan Biosynthesis
S Wopereis, S Grünewald, E Morava, JM Penzien, P Briones, MT Garcı́a-Silva, PN Demacker, KM Huijben, RA Wevers |
Clinical chemistry | 2003 |
Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders
A Onat, G Hergenç, V Sansoy, M Fobker, K Ceyhan, S Toprak, G Assmann |
Atherosclerosis | 2003 |
Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia
S Yamashita, T Maruyama, K Hirano, N Sakai, N Nakajima, Y Matsuzawa |
Atherosclerosis | 2000 |
Characterization of Recombinant Wild Type and Site-Directed Mutations of Apolipoprotein C-III: Lipid Binding, Displacement of ApoE, and Inhibition of Lipoprotein Lipase
H Liu, PJ Talmud, L Lins, R Brasseur, G Olivecrona, F Peelman, J Vandekerckhove, M Rosseneu, C Labeur |
Biochemistry | 2000 |
Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects
R Batal, M Tremblay, PH Barrett, H Jacques, A Fredenrich, O Mamer, J Davignon, JS Cohn |
Journal of lipid research | 2000 |
Characterization of the lipid-binding properties and lipoprotein lipase inhibition of a novel apolipoprotein C-III variant Ala23Thr
H Liu, C Labeur, CF Xu, R Ferrell, L Lins, R Brasseur, M Rosseneu, KM Weiss, SE Humphries, PJ Talmud |
Journal of lipid research | 2000 |
Semi-Automated Rapid Isoelectric Focusing of Apolipoproteins C from Human Plasma Using PhastSystem™ and Immunofixation
B Noll, R Hackler, M Pelzer, S Pelzer, P Nusser, B Maisch, JR Schaefer, A Steinmetz |
Clinical Chemistry and Laboratory Medicine | 1999 |
Fast C18 solid-phase desalting/delipidation of the human serum apolipoproteins for matrix-assisted laser desorption ionization and electrospray ionization mass spectrometric analysis
LK Watkins, PV Bondarenko, DC Barbacci, S Song, SL Cockrill, DH Russell, RD Macfarlane |
Journal of Chromatography A | 1999 |
Role of ApoCs in Lipoprotein Metabolism: Functional Differences Between ApoC1, ApoC2, and ApoC3
MC Jong, MH Hofker, LM Havekes |
Arteriosclerosis, thrombosis, and vascular biology | 1999 |
Mass spectral study of polymorphism of the apolipoproteins of very low density lipoprotein
PV Bondarenko, SL Cockrill, LK Watkins, ID Cruzado, RD Macfarlane |
Journal of lipid research | 1999 |
Transient triglyceridemia in healthy normolipidemic men increases cellular processing of large very low density lipoproteins by fibroblasts in vitro
J Björkegren, F Karpe, S Vitols, P Tornvall, A Hamsten |
Journal of lipid research | 1998 |
A novel apolipoprotein C-III variant, apoC-III(Gln38–>Lys), associated with moderate hypertriglyceridemia in a large kindred of Mexican origin
CR Pullinger, MJ Malloy, AK Shahidi, M Ghassemzadeh, P Duchateau, J Villagomez, J Allaart, JP Kane |
Journal of lipid research | 1997 |
Gene-diet interaction in determining plasma lipid response to dietary intervention
JM Ordovas, J Lopez-Miranda, P Mata, F Perez-Jimenez, AH Lichtenstein, EJ Schaefer |
Atherosclerosis | 1995 |
Characterization of Apolipoproteins B-100, AI and C from Plasma Lipoprotein in the Goose, Anser anser. Evidence for a Genetic Polymorphism in ApoC-like Apolipoproteins
D Hermier, N Sellier, D Rousselot-Pailley, P Forgez |
European Journal of Biochemistry | 1995 |
Atherosclerotic Disease in Marked Hyperalphalipoproteinemia: Combined Reduction of Cholesteryl Ester Transfer Protein and Hepatic Triglyceride Lipase
K Hirano, S Yamashita, Y Kuga, N Sakai, S Nozaki, S Kihara, T Arai, K Yanagi, S Takami, M Menju, M Ishigami, Y Yoshida, K Kameda-Takemura, K Hayashi, Y Matsuzawa |
Arteriosclerosis, thrombosis, and vascular biology | 1995 |
Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol
A Inazu, XC Jiang, T Haraki, K Yagi, N Kamon, J Koizumi, H Mabuchi, R Takeda, K Takata, Y Moriyama |
Journal of Clinical Investigation | 1994 |
Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels
JC Cohen, Z Wang, SM Grundy, MR Stoesz, R Guerra |
Journal of Clinical Investigation | 1994 |
Familial lipoprotein disorders and premature coronary artery disease
EJ Schaefer, JJ Genest, JM Ordovas, DN Salem, PW Wilson |
Atherosclerosis | 1994 |
Genetic factors in coronary heart disease
U Goldbourt, U de Faire, K Berg |
1994 | |
Principles and Treatment of Lipoprotein Disorders
G Schettler, AJ Habenicht |
1994 | |
Overexpression of human apolipoprotein C-III in transgenic mice results in an accumulation of apolipoprotein B48 remnants that is corrected by excess apolipoprotein E
HV de Silva, SJ Lauer, J Wang, WS Simonet, KH Weisgraber, RW Mahley, JM Taylor |
The Journal of biological chemistry | 1994 |
Electrophoretic screening for genetic variation in apolipoprotein C-III: identification of a novel apoC-III variant, apoC-III(Asp45–>Asn), in a Turkish patient
S Lüttmann, A von Eckardstein, W Wei, H Funke, E Köhler, RW Mahley, G Assmann |
Journal of lipid research | 1994 |
Increased production of apolipoprotein A-I associated with elevated plasma levels of high-density lipoproteins, apolipoprotein A-I, and lipoprotein A-I in a patient with familial hyperalphalipoproteinemia
DJ Rader, JR Schaefer, P Lohse, K Ikewaki, F Thomas, WA Harris, LA Zech, CA Dujovne, HB Brewer |
Metabolism | 1993 |
Nucleotide sequences of the Macaca fascicularis apolipoprotein C-III and A-IV genes
J Osada, M Pocoví, RJ Nicolosi, EJ Schaefer, JM Ordovás |
Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression | 1993 |
Advances in Human Genetics 21
H Harris, K Hirschhorn |
1993 | |
Metabolic and genetic control of HDL cholesterol levels
AR Tall |
Journal of Internal Medicine | 1992 |
Determination of Apolipoprotein B in Apolipoprotein CII/CIII-Containing Lipoproteins by an Immunoenzymmetric Assay
M Sandkamp, BM Tambyrajah, G Assmann, H Schriewer |
Clinical Chemistry and Laboratory Medicine | 1992 |
Site-specific methionine sulfoxide formation is the structural basis of chromatographic heterogeneity of apolipoproteins A-I, C-II, and C-III
A von Eckardstein, M Walter, H Holz, A Benninghoven, G Assmann |
Journal of lipid research | 1991 |